(SWK) Stanley Black & Decker - Overview
Stock: Power Tools, Hand Tools, Outdoor Equipment, Industrial Fasteners
| Risk 5d forecast | |
|---|---|
| Volatility | 35.0% |
| Relative Tail Risk | -11.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.34 |
| Alpha | -8.67 |
| Character TTM | |
|---|---|
| Beta | 1.600 |
| Beta Downside | 1.604 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.31% |
| CAGR/Max DD | 0.10 |
EPS (Earnings per Share)
Revenue
Description: SWK Stanley Black & Decker January 04, 2026
Stanley Black & Decker (NYSE:SWK) operates two core segments: Tools & Outdoor, which markets professional-grade power and hand tools, lawn-and-garden equipment, and storage solutions under brands such as DEWALT, CRAFTSMAN, BLACK+DECKER and HUSTLER; and Industrial, which supplies engineered fasteners, rivets, weld studs and related components to automotive, aerospace, construction and electronics manufacturers. Both segments reach customers through a mix of retailers, distributors and direct sales forces.
In FY 2023 the company generated roughly $12.5 billion in revenue, with the Tools & Outdoor segment contributing about 70 % and delivering an adjusted operating margin near 13 %. Free cash flow topped $1.8 billion, supporting a 2.5 % dividend yield and a $2 billion share-repurchase program. The business is highly sensitive to construction activity and housing starts-U.S. residential construction spending grew 4.2 % YoY in Q4 2023-while the Industrial segment tracks cyclical demand in automotive production and aerospace orders.
Key macro drivers include the ongoing rebound in professional construction demand, the DIY “home-improvement” tailwind that boosted retail sales of cordless tools, and supply-chain normalization that is easing component shortages for fasteners. Conversely, a slowdown in housing permits or a prolonged semiconductor shortage could compress margins in the Industrial line.
For a deeper, data-driven view of SWK’s valuation dynamics, you may find ValueRay’s analytical dashboards useful.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 401.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.21 > 1.0 |
| NWC/Revenue: 4.85% < 20% (prev 9.51%; Δ -4.66% < -1%) |
| CFO/TA 0.05 > 3% & CFO 971.2m > Net Income 401.9m |
| Net Debt (5.58b) to EBITDA (1.27b): 4.40 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (152.1m) vs 12m ago 0.28% < -2% |
| Gross Margin: 29.86% > 18% (prev 0.30%; Δ 2956 % > 0.5%) |
| Asset Turnover: 70.22% > 50% (prev 70.33%; Δ -0.10% > 0%) |
| Interest Coverage Ratio: 1.23 > 6 (EBITDA TTM 1.27b / Interest Expense TTM 464.8m) |
Altman Z'' 2.44
| A: 0.03 (Total Current Assets 5.98b - Total Current Liabilities 5.25b) / Total Assets 21.24b |
| B: 0.39 (Retained Earnings 8.21b / Total Assets 21.24b) |
| C: 0.03 (EBIT TTM 570.8m / Avg Total Assets 21.55b) |
| D: 0.74 (Book Value of Equity 9.05b / Total Liabilities 12.19b) |
| Altman-Z'' Score: 2.44 = A |
Beneish M -3.21
| DSRI: 0.81 (Receivables 919.7m/1.15b, Revenue 15.13b/15.37b) |
| GMI: 1.00 (GM 29.86% / 29.76%) |
| AQI: 1.03 (AQ_t 0.63 / AQ_t-1 0.61) |
| SGI: 0.98 (Revenue 15.13b / 15.37b) |
| TATA: -0.03 (NI 401.9m - CFO 971.2m) / TA 21.24b) |
| Beneish M-Score: -3.21 (Cap -4..+1) = AA |
What is the price of SWK shares?
Over the past week, the price has changed by +1.35%, over one month by +7.89%, over three months by +44.70% and over the past year by +9.55%.
Is SWK a buy, sell or hold?
- StrongBuy: 5
- Buy: 1
- Hold: 12
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the SWK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 90.2 | -1% |
| Analysts Target Price | 90.2 | -1% |
| ValueRay Target Price | 102.6 | 12.7% |
SWK Fundamental Data Overview February 12, 2026
P/E Forward = 15.0602
P/S = 0.9267
P/B = 1.5486
P/EG = 1.3679
Revenue TTM = 15.13b USD
EBIT TTM = 570.8m USD
EBITDA TTM = 1.27b USD
Long Term Debt = 4.70b USD (from longTermDebt, last quarter)
Short Term Debt = 1.16b USD (from shortTermDebt, last quarter)
Debt = 5.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.58b USD (from netDebt column, last quarter)
Enterprise Value = 19.61b USD (14.02b + Debt 5.86b - CCE 280.1m)
Interest Coverage Ratio = 1.23 (Ebit TTM 570.8m / Interest Expense TTM 464.8m)
EV/FCF = 28.50x (Enterprise Value 19.61b / FCF TTM 687.9m)
FCF Yield = 3.51% (FCF TTM 687.9m / Enterprise Value 19.61b)
FCF Margin = 4.55% (FCF TTM 687.9m / Revenue TTM 15.13b)
Net Margin = 2.66% (Net Income TTM 401.9m / Revenue TTM 15.13b)
Gross Margin = 29.86% ((Revenue TTM 15.13b - Cost of Revenue TTM 10.61b) / Revenue TTM)
Gross Margin QoQ = 33.16% (prev 30.65%)
Tobins Q-Ratio = 0.92 (Enterprise Value 19.61b / Total Assets 21.24b)
Interest Expense / Debt = 1.39% (Interest Expense 81.4m / Debt 5.86b)
Taxrate = 30.61% (69.8m / 228.0m)
NOPAT = 396.1m (EBIT 570.8m * (1 - 30.61%))
Current Ratio = 1.14 (Total Current Assets 5.98b / Total Current Liabilities 5.25b)
Debt / Equity = 0.65 (Debt 5.86b / totalStockholderEquity, last quarter 9.05b)
Debt / EBITDA = 4.40 (Net Debt 5.58b / EBITDA 1.27b)
Debt / FCF = 8.12 (Net Debt 5.58b / FCF TTM 687.9m)
Total Stockholder Equity = 8.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.87% (Net Income 401.9m / Total Assets 21.24b)
RoE = 4.47% (Net Income TTM 401.9m / Total Stockholder Equity 8.98b)
RoCE = 4.17% (EBIT 570.8m / Capital Employed (Equity 8.98b + L.T.Debt 4.70b))
RoIC = 2.53% (NOPAT 396.1m / Invested Capital 15.64b)
WACC = 8.61% (E(14.02b)/V(19.89b) * Re(11.81%) + D(5.86b)/V(19.89b) * Rd(1.39%) * (1-Tc(0.31)))
Discount Rate = 11.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.73%
[DCF Debug] Terminal Value 67.48% ; FCFF base≈713.9m ; Y1≈468.7m ; Y5≈213.8m
Fair Price DCF = N/A (negative equity: EV 3.78b - Net Debt 5.58b = -1.81b; debt exceeds intrinsic value)
EPS Correlation: 24.31 | EPS CAGR: -10.08% | SUE: 0.67 | # QB: 0
Revenue Correlation: -81.27 | Revenue CAGR: -4.90% | SUE: -1.71 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.63 | Chg30d=-0.379 | Revisions Net=-3 | Analysts=10
EPS current Year (2026-12-31): EPS=5.39 | Chg30d=-0.188 | Revisions Net=-5 | Growth EPS=+15.5% | Growth Revenue=+1.0%
EPS next Year (2027-12-31): EPS=6.39 | Chg30d=-0.114 | Revisions Net=-4 | Growth EPS=+18.4% | Growth Revenue=+2.7%